Brenda SnowAuthentic Patient Voice
Paul TheisenPatient Acquisition
Suma Ramadas, PhDMedical Affairs
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Joey CohenMedication Adherence
Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Pat PurcellMeeting Engagement
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
David LinetskyPoint-of-Care Marketing
YELIVA®, a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email